Skip to search.
 FTSE 100 Up 0.42%
Streaming
Ticker Tape: On

Hyperion Therapeutics, Inc. (HPTX)

-NasdaqGM

20.74 Down 0.90(4.16%) 16:32 - Nasdaq Real Time Price

Add to Portfolio
Prev Close:21.64
Open:20.54
Bid:20.54 x 400
Ask:20.75 x 100
1y Target Est:29.33
Beta:5.740
Next Earnings Date:N/A
Day's Range:20.57 - 21.55
52wk Range:9.95 - 26.50
Volume:68,421
Avg Vol (3m):119,773
Market Cap:415.67m
P/E (ttm):N/A
EPS (ttm):-2.56
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for HPTX at this time.

Comparison

Symbol% ChgMkt Cap
HPTXDown 4.16%415.67m
RHHBYN.MXUp 0.14%2.66t
SHP.LUp 1.82%11.71b
SUNPHARMA.NSUp 0.83%1.01t
GILD.MXUp 0.11%1.04t
» More Competitors

Key Statistics

Forward P/E (1 yr):20.83
P/S (ttm):553.91
Ex-Dividend Date:N/A
» More Key Statistics

Analysts

Annual EPS Est (Dec-13) :-0.60
Quarterly EPS Est (Jun-13) :-0.11
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Hyperion Therapeutics, Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics to treat disorders in the areas of orphan diseases and hepatology. more
Company Profile | Industry
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback